Ariel Precision Medicine, Inc.

[Available On-Demand] ・ Click video to start playback; Join chat Q&A below video
Search General Info
Ariel is a genomic health technology company seamlessly integrating complex genetics into clinical decision making to enable an earlier diagnosis and expert management of complex chronic gastrointestinal and metabolic diseases.

ADVANCE®, Ariel’s proprietary cloud based advanced intelligence platform leverages interrelated expert system models of systems biology, evidence-based medicine, genetic drivers and biomarkers to serve multiple stakeholders in the healthcare ecosystem. We partner with Pharma to enable novel patient segmentation for clinical trials. Ariel generated $1 M in revenue in 2019 for our first tools in pancreatic diseases and are moving our solutions into other complex diseases like IBD and NASH.
Speaker
photo
CEO and Co-Founder
Ariel Precision Medicine, Inc.